Form Filed By Ayabudge LLC
Thu, Aug 26, 2021
Go to original document
Humacyte, Inc. (HUMAW)
Healthcare
Biotechnology
Insights
Coming soon
Non Derivative Transactions
2021-08-26
Common Stock
Award
A
Type
Acquired 18,930,004 shares @ $0.00 per share
18,930,004 shares
Direct
2021-08-26
Common Stock
Purchase
P
Type
Acquired 1,522,500 shares @ $10.00 per share
20,452,504 shares
Direct
Footnotes
1. On August 26, 2021, Alpha Health care Acquisition Corp. ("AHAC") consummated a business combination (the "Business Combination") by and among AHAC, Hunter Merger Sub, Inc., a Delaware corporation ("Hunter Merger Sub") and Humacyte, Inc., a Delaware corporation ("Legacy Humacyte"), AHAC changed its name to "Humacyte, Inc." and Hunter Merger Sub merged with and into Legacy Humacyte. As part of the Business Combination, each share of Legacy Humacyte stock was exchanged for 0.2626 shares of common stock of Humacyte, Inc.